clopidogrel and Diabetes Mellitus

clopidogrel has been researched along with Diabetes Mellitus in 126 studies

Research

Studies (126)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	26 (20.63)	29.6817
2010's	72 (57.14)	24.3611
2020's	28 (22.22)	2.80

Authors

Authors	Studies
Altınay, L; Çetin, E	1
Donia, HM; El-Askary, NA; El-Behery, AM; El-Khodary, NM; Omran, GA	1
Chen, Z; Dai, L; Li, H; Meng, X; Pan, Y; Wang, Y; Xu, J; Yan, H	1
Han, Y; He, P; Huang, L; Jin, J; Li, J; Li, Y; Luo, X; Wang, X	1
Buzzetti, R; Cavallari, I; Grigioni, F; Maddaloni, E; Mangiacapra, F; Patti, G; Ricottini, E; Ussia, GP; Veneziano, F	1
França, ACW; Macedo, LSDN; Magliano, CADS; Meirelles, I; Piccin Padilla, M; Santos, MDS	1
Angiolillo, DJ; Been, L; Franchi, F; Galli, M; Rollini, F; Zenni, MM	1
Ben-Yehuda, O; Brodie, BR; Cox, DA; Duffy, PL; Henry, TD; Kirtane, AJ; Liu, M; Madhavan, MV; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Redfors, B; Rinaldi, MJ; Shahim, B; Srdanovic, I; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Zhou, Z	1
Ando, K; Domei, T; Fujii, S; Hayashi, F; Isawa, T; Ishii, M; Kimura, T; Komiyama, K; Mori, H; Morimoto, T; Natsuaki, M; Nikaido, A; Nishikura, T; Obayashi, Y; Ogita, M; Ohya, M; Shigematsu, T; Suematsu, N; Suwa, S; Suzuki, H; Tada, T; Tatsushima, S; Watanabe, H; Watanabe, N; Yamaji, K; Yamamoto, K	1
Cao, D; Gragnano, F	1
Bae, JW; Bong, JM; Chun, KJ; Han, JK; Hwang, D; Kang, HJ; Kang, J; Kim, HS; Kim, SY; Koo, BK; Lee, BK; Lee, KS; Lee, NH; Lim, HS; Lim, YH; Park, K; Park, KH; Park, KW; Rha, SW; Rhew, JY; Shin, WY; Yang, HM	1
Bae, JW; Chae, IH; Han, JK; Hur, SH; Jeong, MH; Kang, J; Kim, DK; Kim, HS; Kim, YH; Koo, BK; Kwak, SH; Lee, H; Lee, NH; Oh, JH; Park, KW; Rha, SW; Rhee, TM; Shin, ES; Shin, WY; Yang, HM; Yoon, J	1
Schumacher, B	1
Goto, H; Kitahara, H; Kobayashi, Y; Matsumoto, T; Saito, Y; Sano, K; Sato, T; Suzuki, S; Wakabayashi, S; Yamashita, D	1
Ahn, SG; Chae, IH; Chang, K; Cho, JR; Her, AY; Jeon, KH; Jeong, YH; Joo, HJ; Kim, BK; Kim, HS; Kim, MH; Lee, SY; Lim, DS; Park, Y; Shin, ES; Song, YB; Suh, JW	1
Kafian, S; Mobarrez, F; Samad, BA; Wallén, H	1
Barbato, E; Bressi, E; Capuano, M; Cavallari, I; Colaiori, I; Di Sciascio, G; Mangiacapra, F; Ricottini, E; Spoto, S; Viscusi, MM	1
Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Maeng, M; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Angiolillo, DJ; Bergmeijer, TO; Capodanno, D; Danchin, N; Price, MJ; Sibbing, D; Simon, T; Ten Berg, JM	1
Ajjan, RA; Naseem, KM; Sagar, RC	1
Hsieh, MH; Hsieh, YC; Huang, CY; Lin, YK; Liu, JC; Wang, CA; Yeh, JS	1
Kreutz, RP	1
AbdElghany, M; El-Abhar, HS; Mohareb, MW; Zaki, HF	1
Cai, ZX; Dou, KF; Song, WH; Wang, HY; Yang, YJ; Yin, D	1
Beasley, M; Brown, TM; Cai, A; Clarkson, SA; Dillon, C; Heindl, B; Limdi, N	1
Hatakeyama, Y; Horino, T; Matsumoto, T; Okuhara, Y; Terada, Y	1
Abou Jaoude, P; Angiolillo, DJ; Bass, TA; Been, L; Briceno, M; Franchi, F; Jia, S; Lee, CH; Maaliki, N; Pineda, AM; Rivas, A; Rollini, F; Soffer, D; Suryadevara, S; Zenni, MM; Zhou, X	1
Bastos-Fernandez, G; Baz-Alonso, JA; Cruz-González, I; De Miguel-Castro, A; Fernández-Barbeira, S; Figueiras-Guzman, A; Iñiguez-Romo, A; Jimenez-Diaz, VA; Molina-Navarro, E; Moreno, R; Ortiz-Saez, A; Paredes-Galán, E; Romaguera, R; Salvadores, PJ; Tello-Montoliu, A; Trejo-Velasco, B	1
Ariyoshi, N; Kitahara, H; Kobayashi, Y; Nishi, T; Ohno, Y; Saito, Y; Wakabayashi, S	1
Guo, L; Man, F; Pan, Q; Wang, W; Wang, X; Zhang, J; Zhang, L	1
Angiolillo, DJ; Carlson, GF; Dangas, G; Franchi, F; Khan, ND; Mehran, R; Raveendran, G; Rollini, F; Sweeny, JM; Teng, R; Waksman, R; Zhao, Y	1
Van de Werf, F	1
Armstrong, PW; Bhatt, DL; Cyr, DD; Dalby, AJ; Fox, KAA; Gottlieb, S; Magnus Ohman, E; McGuire, DK; Prabhakaran, D; Roe, MT; Ruzyllo, W; White, HD; Winters, KJ; Wiviott, SD	1
Bognetti, P; Cardile, A; De Servi, S; Demarchi, A; Ferlini, M; Frattini, S; Grieco, N; Ielasi, A; Lettieri, C; Mafrici, A; Musumeci, G; Rossini, R; Russo, A; Sponzilli, C; Vecchiato, C; Visconti, LO	1
C, K; Durgaprasad, R; Erathi, HV; Kanavath, SN; Pvgk, S; Rodda, M; Velam, V	1
Desai, RJ; Gagne, JJ; Mogun, H; Spoendlin, J	1
Alexopoulos, D; Goudevenos, J; Hamilos, M; Kanakakis, J; Kochiadakis, G; Lekakis, J; Petousis, S; Sitafidis, G; Skalidis, E; Vardas, PE; Vavouranakis, M; Xanthopoulou, I	1
Assanelli, EM; Camisasca, P; Chizzola, G; Corrada, E; De Servi, S; Demarchi, A; Farina, A; Ferlini, M; Grieco, N; Lettieri, C; Mafrici, A; Musumeci, G; Oltrona Visconti, L; Pedrinazzi, C; Rossini, R; Sponzilli, C	1
Abderrazak, F; Abroug, H; Ben Hamda, K; Chouchene, S; Dabboubi, R; Gaaloul, M; Hadj Fredj, S; Hassine, M; Hellara, I; Khefacha, L; Maatouk, F; Messaoud, T; Najjar, MF; Neffeti, F; Nouira, S; Raddaoui, H; Rezek, M; Sassi, M; Sriha, A	1
Desai, RJ; Gagne, JJ; Lewey, JJ; Patorno, E; Schneeweiss, S; Spoendlin, J	1
Aquino, M; Baber, U; Baker, B; Chandrasekhar, J; Claessen, BE; Defranco, A; Effron, MB; Faggioni, M; Farhan, S; Henry, T; Kapadia, S; Keller, S; Kini, A; Mehran, R; Muhlestein, JB; Pocock, S; Poddar, K; Rao, SV; Sartori, S; Snyder, C; Sorrentino, S; Strauss, C; Toma, C; Vogel, B; Weintraub, W; Weiss, S	1
Briguori, C; Condorelli, G; D'Alessio, F; D'Amore, C; De Caterina, R; Del Vecchio, L; Donahue, M; Quintavalle, C; Signoriello, G	1
Angiolillo, DJ; Budaj, AJ; Cornel, JH; Franchi, F; Ghukasyan Lakic, T; Himmelmann, A; James, SK; Katus, HA; Keltai, M; Kontny, F; Lewis, BS; Storey, RF; Wallentin, L	1
Ahn, KT; Chae, SC; Cho, MC; Choi, SW; Choi, UL; Gwon, HC; Jeong, JO; Jeong, MH; Jin, SA; Kim, CJ; Kim, HS; Kim, JH; Kim, YJ; Lee, JH; Seong, IW; Seong, SW	1
Briguori, C; Condorelli, G; D'Alessio, F; D'Amore, C; De Caterina, R; Donahue, M; Quintavalle, C; Signoriello, G	1
Carriero, A; De Luca, G; Kedhi, E; Nardin, M; Pergolini, P; Rolla, R; Suryapranata, H; Tonon, F; Verdoia, M	1
Chen, Y; He, Z; Hultgårdh-Nilsson, A; Liang, C; Wang, J; Xu, J	1
Carriero, A; De Luca, G; Kedhi, E; Marcolongo, M; Nardin, M; Negro, F; Pergolini, P; Rolla, R; Suryapranata, H; Verdoia, M	1
Ding, LY; Li, XZ; Liu, Y	1
Capodanno, D; Capranzano, P	1
Kang, HJ; Kang, J; Kim, HS; Koo, BK; Kwon, YW; Lee, HY; Oh, BH; Park, JJ; Park, KW; Park, YB; Yang, HM	1
Baber, U; Badimon, JJ; Bander, J; Gukathasan, N; Hadi, A; Karajgikar, R; Kini, AS; Kovacic, JC; Mehran, R; Moreno, P; Muntner, P; Roy, S; Sartori, S; Sayeneni, S; Scott, SA; Sharma, SK; Theodoropolous, K; Uribarri, J; Yadav, K; Yu, J	1
Abbate, R; Angiolillo, DJ; Bellandi, F; Giusti, B; Leoncini, M; Maioli, M; Marcucci, R; Toso, A	1
Angiolillo, DJ; Bender, N; Darlington, A; Desai, B; Franchi, F; Muñiz-Lozano, A; Patel, R; Rollini, F; Sakariassen, KS; Tello-Montoliu, A; Wilson, RE	1
Akasaka, T; Arima, Y; Hokimoto, S; Kaikita, K; Miyazaki, H; Mizobe, M; Morita, K; Nakagawa, K; Ogawa, H; Oniki, K	1
Abd Elghany, M; Farid, SF; Mohareb, MW; Sabry, NA	1
Daels, FP; de la Rosette, JJ; Erkan, E; Gaizauskas, A; Melekos, M; Ozgok, Y; Rioja, J; Varshney, AK	1
Chae, IH; Cho, YS; Choi, DJ; Kim, HS; Kim, SH; Lee, SA; Park, JJ; Suh, JW; Yoon, CH; Youn, TJ	1
Kioufis, S; Kokkou, E; Mourouzis, K; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stone, PH; Tousoulis, D; Vavuranakis, M; Vlasis, K; Zaromitidou, M	1
Abbate, R; Antoniucci, D; Cantini, G; Carrabba, N; Cerisano, G; Comito, V; Gensini, GF; Gori, AM; Marcucci, R; Marrani, M; Migliorini, A; Parodi, G; Valenti, R; Vergara, R	1
Agrawal, K; Cho, K; Dufour, AB; Faxon, DP; Gagnon, DR; Gaziano, JM; Kinlay, S; Ly, S; Prince, L; Smoot, KJ; Sokolovskaya, G; Temiyasathit, S; Thukkani, AK	1
Angiolillo, DJ; Caplan, R; Carlson, G; Clavijo, LC; Maya, J; Price, MJ; Teng, R	1
Hironaka, Y; Kichikawa, K; Motoyama, Y; Nakagawa, I; Nakase, H; Park, HS; Takayama, K; Wada, T; Yokoyama, S	1
Brodie, BR; Clemmensen, P; Cox, DA; Dangas, GD; Duffy, PL; Henry, TD; Kirtane, AJ; Litherland, C; Maehara, A; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Rinaldi, MJ; Schoos, MM; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Yu, J	1
Bell, DS	1
Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M	1
Ariti, C; Baber, U; Chieffo, A; Cohen, DJ; Colombo, A; Dangas, G; Gibson, CM; Giustino, G; Henry, TD; Kini, AS; Kirtane, AJ; Krucoff, MW; Litherland, C; Mehran, R; Moliterno, DJ; Pocock, S; Sartori, S; Steg, PG; Stone, GW; Weisz, G; Witzenbichler, B	1
Angiolillo, DJ; Barozzi, C; Bartorelli, A; Calabrò, P; Capodanno, D; Cattaneo, M; Crimi, G; De Carlo, M; De Servi, S; Della Riva, D; Maffeo, D; Palmerini, T; Palmieri, C; Piscione, F; Tomasi, L; Toso, A	1
Horenstein, RB; Jiang, XL; Lesko, LJ; Lewis, JP; Peletier, LA; Samant, S; Schmidt, S; Shuldiner, AR	1
Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS	1
Bekta, P; Chmielak, Z; Debski, A; Jamiolkowski, J; Klopotowski, M; Kukula, K; Kunicki, PK; Polanska-Skrzypczyk, M; Witkowski, A	1
Abizaid, A; Costa, JR; Costa, R; Feres, F; Mangione, JA; Piva E Mattos, LA; Siqueira, D; Sousa, A; Staico, R; Zuliani Mauro, MF	1
Aharonian, V; Brar, SK; Brar, SS; Hyett, R; Kim, J; Liu, IL; Mansukhani, P; Ree, M; Shen, AY; Zadegan, R	1
Choi, SH; Prasad, A; Tsimikas, S	1
Badimon, J; Chesebro, J; Kuliczkowski, W; Pokov, I; Serebruany, V	1
Cerbone, AM; Coppola, A; Di Minno, G; Macarone-Palmieri, N; Rivellese, AA; Saldalamacchia, G	1
Angiolillo, DJ	1
Björnberg, A; Odén, A; Welin, L; Wilhelmsen, L	1
Eberli, FR; Roffi, M	1
Angiolillo, DJ; Suryadevara, S	1
Bhatt, DL; Cannon, CP; Depta, JP; Fonarow, GC; Peacock, WF; Zhao, X	1
Bigalke, B; Gawaz, M; Henkelmann, N; Stakos, D; Stellos, K	1
Alessi, MC; Cuisset, T; Dutour, A; Frère, C; Gaborit, B	2
Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Fineschi, M; Gori, T; Grotti, S; Liistro, F; Pierli, C	1
Alfonso, F; Angiolillo, DJ; Bass, TA; Bernardo, E; Capodanno, D; Fernandez-Ortiz, A; Ferreiro, JL; Jimenez-Quevedo, P; Macaya, C; Sabaté, M; Ueno, M; Vivas, D	1
Bareiss, P; Kessler, L; Morel, O; Ohlmann, P	1
Amin, AP; Marso, SP	1
Cho, HJ; Jeon, KH; Kang, HJ; Kang, SH; Kim, HS; Koo, BK; Lee, HY; Oh, BH; Oh, IY; Park, JJ; Park, KW; Park, YB; Yang, HM	1
Farhan, S; Huber, K; Jarai, R; Siller-Matula, J; Tentzeris, I; Wojta, J	1
Angiolillo, DJ; Bass, TA; Box, LC; Capodanno, D; Capranzano, P; Charlton, RK; Darlington, A; Desai, B; Dharmashankar, K; Ferreiro, JL; Guzman, LA; Sumner, S; Ueno, M; Zenni, M	1
Carballo, D; Carballo, S; Keller, PF; Roffi, M	1
Ajani, AE; Andrianopoulos, N; Brennan, AL; Clark, DJ; Duffy, SJ; Loane, P; Reid, CM; Yan, BP	1
Barone-Rochette, G; Danchin, N; Foote, A; Machecourt, J; Motreff, P; Quesada, JL; Vanzetto, G	1
Al Suwaidi, J; Alsheikh-Ali, AA; Anderson, FA; Awad, HH; Goldberg, RJ; Gore, JM; Zubaid, M	1
D'Urbano, M; De Servi, S; Navarese, EP; Savonitto, S	1
Abizaid, A; Chamié, D; Collet, CA; Costa, JR; Costa, R; Feres, F; Obregon, J; Siquera, D; Sousa, A; Sousa, JE; Staico, R	1
Kocka, V; Osmancik, P; Paulu, P; Tousek, P; Widimsky, P	1
Desta, Z; Flockhart, DA; Jin, Y; Kovacs, R; Kreutz, RP; Kreutz, Y; Miao, J; Nystrom, P	1
Arauz, A; Benavente, MF; Benavente, OR; Coffey, CS; Conwit, R; Del Brutto, OH; Demaerschalk, BM; Hart, RG; Irby, LH; Kase, CS; McClure, LA; Meissner, I; Meyer, BC; Pearce, LA; Pergola, PE; Peri, K; Pretell, EJ; Roldan, A; Szychowski, JM; White, CL	1
Crimizade, U; El Ghannudi, S; Gachet, C; Hess, S; Jesel, L; Morel, O; Ohlmann, P; Radulescu, B; Reydel, A; Wiesel, ML	1
Chen, X; Han, Y; Jiang, T; Jing, Q; Li, Y; Liu, H; Ma, Y; Wang, G; Wang, S; Wang, X; Yan, G; Yang, L; Zhang, L; Zhu, G	1
Andersson, C; Gislason, GH; Køber, L; Lyngbæk, S; Nguyen, CD; Nielsen, M; Torp-Pedersen, C	1
Bhatt, DL	1
Alessi, MC; Beguin, S; Bonnet, JL; Cuisset, T; Dubois, N; Dutour, A; Gaborit, B; Loosveld, M; Loundou, AD; Morange, PE; Moro, PJ; Quilici, J	1
Bao, Y; Hua, Y; Jiang, L; Jiao, L; Li, S; Li, Y; Ling, F; Liu, X; Miao, Z; Wu, H; Wu, J; Zhu, F; Zhu, J	1
Angiolillo, DJ; Bass, TA; Capodanno, D; Darlington, A; Desai, B; Ferreiro, JL; Guzman, LA; Kodali, MK; Patel, R; Rollini, F; Tello-Montoliu, A; Tomasello, SD; Ueno, M	1
Argay, M; Dormaeva, I; Hankó, B; Koós, I; Meskó, A; Takács, I; Zelkó, R	1
Bhatt, DL; Hacke, W; Hirsch, AT; Marso, SP; Ringleb, PA; Topol, EJ	1
Cannon, CP	1
Dirkali, A; Umans, VA	1
Colombo, A; Desmedt, B; Di Mario, C; Holmes, DR; Leon, MB; Louvard, Y; Ludwig, J; Morice, MC; Moses, JW; Spanos, V	1
Bakhai, A; Berezin, RH; Carrozza, JP; Cohen, DJ; Githiora, L; Kuntz, RE; Lavelle, T; Leon, MB; Moses, JW; Shi, C; Zidar, JP	1
Bhatt, DL; Hirsh, J	1
Schnell, O; Standl, E	1
Baysan, O; Erinc, K; Isik, E; Ozkan, M; Sag, C; Uzun, M; Yokusoglu, M	1
Hacke, W	1
Alfonso, F; Angiolillo, DJ; Bañuelos, C; Bass, TA; Bernardo, E; Costa, MA; Escaned, J; Fernandez-Ortiz, A; Hernández, R; Jimenez-Quevedo, P; Macaya, C; Moreno, R; Ramírez, C; Sabaté, M	2
Gulba, DC; Klutmann, M; Tillmanns, C	1
Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E	1
Cho, YH; Choi, SW; Chun, KJ; Hong, MK; Kim, HS; Kim, JH; Kim, YH; Ko, JK; Lee, CW; Lee, JH; Lee, NH; Lee, SW; Park, DW; Park, JH; Park, SJ; Park, SW; Seong, IW; Yun, SC	1
Brandslund, I; Buck, TC; Christensen, C; Jørgensen, LG; Nielsen, AA; Veien, KT	1
Batchelor, WB; Buchbinder, M; Dubois, CL; Fitzgerald, PJ; Gammon, R; Garg, J; Hasselblad, V; Hermiller, JB; Kereiakes, DJ; Krucoff, MW; Lansky, AJ; Mehran, R; O'Shaughnessy, CD; Petersen, JL; Schofer, J; Simonton, CA; Turco, MA; Verheye, S; Wijns, W	1
Bassus, S; Franz, N; Graff, J; Harder, S; Kirchmaier, CM; Klinkhardt, U; Schini-Kerth, VB	1

Reviews

12 review(s) available for clopidogrel and Diabetes Mellitus

Article	Year
Antiplatelet therapies in diabetes. Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:5 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Primary Prevention; Secondary Prevention; Thrombosis; Ticagrelor	2020
Dual antiplatelet therapy in patients with diabetes mellitus: special considerations. Expert review of cardiovascular therapy, 2013, Volume: 11, Issue:3 Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2013
Diabetes, vascular complications and antiplatelet therapy: open problems. Acta diabetologica, 2009, Volume: 46, Issue:4 Topics: Aspirin; Clopidogrel; Diabetes Mellitus; Diabetic Angiopathies; Drug Interactions; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2009
Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions. Diabetes care, 2009, Volume: 32, Issue:4 Topics: Aspirin; Clopidogrel; Diabetes Mellitus; Diabetic Angiopathies; Drug Resistance; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Secondary Prevention; Ticlopidine	2009
Diabetes and acute coronary syndromes. Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:3 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enoxaparin; Hirudins; Humans; Hypoglycemic Agents; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Recombinant Proteins; Thiophenes; Thrombosis; Ticlopidine	2009
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus. Best practice & research. Clinical endocrinology & metabolism, 2009, Volume: 23, Issue:3 Topics: Aspirin; Clopidogrel; Diabetes Mellitus; Drug Resistance; Endothelium, Vascular; Humans; Ischemia; Oxidative Stress; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine	2009
Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis. Atherosclerosis, 2010, Volume: 212, Issue:2 Topics: Acute Coronary Syndrome; Apoptosis; Aspirin; Blood Platelets; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Glycoproteins; Humans; Models, Biological; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Receptors, Purinergic P2Y12; Thiophenes; Thromboplastin; Thrombosis; Ticlopidine	2010
Acute coronary syndrome in the patient with diabetes: is the management different? Current cardiology reports, 2010, Volume: 12, Issue:4 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Diabetes Mellitus; Drug-Eluting Stents; Humans; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Risk Factors; Thiophenes; Ticlopidine	2010
Platelet function variability and non-genetic causes. Thrombosis and haemostasis, 2011, Volume: 105 Suppl 1 Topics: Blood Platelets; Clinical Trials as Topic; Clopidogrel; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Drug Interactions; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2011
Treating acute coronary syndromes with new antiplatelet drugs: the mortality issue with prasugrel and ticagrelor. Current medical research and opinion, 2011, Volume: 27, Issue:11 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Angiography; Diabetes Mellitus; Female; Humans; Hypertension; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2011
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Archives of internal medicine, 2004, Oct-25, Volume: 164, Issue:19 Topics: Angina, Unstable; Aspirin; Clopidogrel; Comorbidity; Diabetes Mellitus; Humans; Hypercholesterolemia; Myocardial Ischemia; Platelet Aggregation Inhibitors; Recurrence; Risk; Ticlopidine	2004
[Cardiovascular risk in diabetes--diagnostic and therapeutic aspects]. MMW Fortschritte der Medizin, 2004, Sep-02, Volume: 146, Issue:35-36 Topics: Abciximab; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Aspirin; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Glucose Tolerance Test; Humans; Hypolipidemic Agents; Immunoglobulin Fab Fragments; Insulin; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Primary Prevention; Risk; Risk Factors; Stents; Ticlopidine; Time Factors	2004

Trials

32 trial(s) available for clopidogrel and Diabetes Mellitus

Article	Year
Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes. Cardiovascular therapeutics, 2021, Volume: 2021 Topics: Acute Coronary Syndrome; Clopidogrel; Diabetes Mellitus; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Ticagrelor; Treatment Outcome	2021
Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease. Journal of thrombosis and thrombolysis, 2022, Volume: 54, Issue:3 Topics: Adenosine; Adenosine Diphosphate; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Ticagrelor	2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention. JACC. Cardiovascular interventions, 2023, 01-09, Volume: 16, Issue:1 Topics: Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Treatment Outcome	2023
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial. European heart journal. Cardiovascular pharmacotherapy, 2023, 04-10, Volume: 9, Issue:3 Topics: Acute Coronary Syndrome; Brain Ischemia; Clopidogrel; Diabetes Mellitus; Hemorrhage; Humans; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke	2023
Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial. JAMA cardiology, 2023, 06-01, Volume: 8, Issue:6 Topics: Aspirin; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies	2023
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes. JACC. Cardiovascular interventions, 2019, 12-09, Volume: 12, Issue:23 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Diabetes Mellitus; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin	2019
Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention-treated Acute Coronary Syndrome Patients. Journal of cardiovascular pharmacology, 2020, Volume: 76, Issue:4 Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Clopidogrel; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Egypt; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Purinergic P2Y Receptor Antagonists; Recurrence; Risk Assessment; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Young Adult	2020
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. European heart journal. Cardiovascular pharmacotherapy, 2022, 08-11, Volume: 8, Issue:5 Topics: Clopidogrel; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Renal Insufficiency, Chronic; Ticagrelor	2022
Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation. Journal of cardiovascular pharmacology, 2021, 09-01, Volume: 78, Issue:3 Topics: Aged; Aged, 80 and over; Anemia; Aortic Valve Stenosis; Aspirin; Blood Platelets; Clopidogrel; Comorbidity; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prevalence; Prospective Studies; Renal Insufficiency, Chronic; Severity of Illness Index; Spain; Ticagrelor; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome	2021
Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization. American heart journal, 2017, Volume: 188 Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Diabetes Mellitus; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Ticlopidine; Time Factors; Treatment Outcome	2017
Predictors of strut coverage of drug eluting stent implantation in diabetic patients. International journal of cardiology, 2019, Feb-01, Volume: 276 Topics: Aged; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prosthesis Design; Sirolimus; Tomography, Optical Coherence; Treatment Outcome	2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Journal of the American Heart Association, 2019, 03-19, Volume: 8, Issue:6 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Comorbidity; Diabetes Mellitus; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Rate; Ticagrelor; United States	2019
Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus status. Journal of thrombosis and thrombolysis, 2014, Volume: 37, Issue:4 Topics: Aged; Atorvastatin; Clopidogrel; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Thrombosis; Ticlopidine	2014
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigation. Journal of thrombosis and thrombolysis, 2014, Volume: 37, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Ticlopidine	2014
The impact of a 600-mg loading dose of clopidogrel in diabetic and non-diabetic patients undergoing elective PCI. Minerva cardioangiologica, 2016, Volume: 64, Issue:4 Topics: Aged; Clopidogrel; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Stents; Ticlopidine; Treatment Outcome	2016
Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study. Contemporary clinical trials, 2015, Volume: 43 Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Hepatic Insufficiency; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Renal Insufficiency, Chronic; Republic of Korea; Research Design; Serotonin Antagonists; Succinates; Ticlopidine	2015
Platelet inhibition with ticagrelor versus clopidogrel in Hispanic patients with stable coronary artery disease with or without diabetes mellitus. Cardiovascular revascularization medicine : including molecular interventions, 2015, Volume: 16, Issue:8 Topics: Adenosine; Administration, Oral; Aged; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Over Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hispanic or Latino; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Regression Analysis; Risk Assessment; Severity of Illness Index; Ticagrelor; Ticlopidine; Treatment Outcome; United States	2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). The American journal of cardiology, 2016, Jan-15, Volume: 117, Issue:2 Topics: Acute Coronary Syndrome; Blood Platelets; Clopidogrel; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine	2016
Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients. The Journal of invasive cardiology, 2017, Volume: 29, Issue:3 Topics: Aspirin; Cilostazol; Clopidogrel; Comorbidity; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Neointima; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Treatment Outcome	2017
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. Thrombosis and haemostasis, 2011, Volume: 106, Issue:2 Topics: Aged; Aspirin; Blood Platelets; Chemotherapy, Adjuvant; Cilostazol; Clopidogrel; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Receptors, Purinergic P2Y12; Signal Transduction; Tetrazoles; Thrombin; Ticlopidine	2011
Assessing the temporal course of neointimal hyperplasia formation after different generations of drug-eluting stents. JACC. Cardiovascular interventions, 2011, Volume: 4, Issue:10 Topics: Clopidogrel; Coronary Angiography; Coronary Restenosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Neointima; Risk Factors; Sirolimus; Statistics as Topic; Statistics, Nonparametric; Ticlopidine; Time Factors; Ultrasonography, Interventional	2011
High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel. Journal of thrombosis and thrombolysis, 2012, Volume: 33, Issue:4 Topics: Age Factors; Aged; Biomarkers; CD40 Ligand; Clopidogrel; Diabetes Mellitus; Drug Resistance; Female; Humans; Inflammation; Interleukin-10; Leukocyte Count; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2012
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:6 Topics: Aged; Antihypertensive Agents; Aspirin; Black or African American; Blood Pressure; Chi-Square Distribution; Clopidogrel; Diabetes Mellitus; Drug Administration Schedule; Drug Therapy, Combination; Ethnicity; Female; Hispanic or Latino; Humans; Hypertension; Magnetic Resonance Imaging; Male; Middle Aged; North America; Platelet Aggregation Inhibitors; Prevalence; Racial Groups; Risk Factors; Secondary Prevention; Smoking; South America; Spain; Stroke; Ticlopidine; Time Factors; Treatment Outcome; White People	2013
Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population. Stroke, 2012, Volume: 43, Issue:12 Topics: Adult; Aged; Angioplasty; Asian People; Aspirin; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperlipidemias; Hypertension; Infarction, Middle Cerebral Artery; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Secondary Prevention; Stents; Ticlopidine; Treatment Outcome	2012
Impact of renal function on clopidogrel-induced antiplatelet effects in coronary artery disease patients without diabetes mellitus. Journal of thrombosis and thrombolysis, 2013, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine	2013
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. The American journal of cardiology, 2002, Sep-15, Volume: 90, Issue:6 Topics: Aged; Aspirin; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Endpoint Determination; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Patient Readmission; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Ticlopidine; Treatment Outcome	2002
Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial). The American journal of cardiology, 2002, Oct-01, Volume: 90, Issue:7 Topics: Age Factors; Aged; Aspirin; Clopidogrel; Creatinine; Diabetes Mellitus; Female; Humans; Male; Massachusetts; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Survival Analysis; Thrombosis; Ticlopidine; Treatment Outcome	2002
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 2004, Mar-16, Volume: 109, Issue:10 Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Death, Sudden; Diabetes Mellitus; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Safety; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome	2004
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation, 2004, Aug-03, Volume: 110, Issue:5 Topics: Angioplasty, Balloon, Coronary; Cardiac Catheterization; Clopidogrel; Coronary Restenosis; Cost-Benefit Analysis; Diabetes Mellitus; Double-Blind Method; Drug Costs; Equipment Design; Female; Follow-Up Studies; Health Care Costs; Health Resources; Hospital Costs; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Sirolimus; Stents; Ticlopidine; Treatment Outcome; United States	2004
The effect of tirofiban and clopidogrel pretreatment on outcome of old saphenous vein graft stenting in patients with acute coronary syndromes. The Tohoku journal of experimental medicine, 2005, Volume: 206, Issue:1 Topics: Acute Disease; Clopidogrel; Coronary Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Saphenous Vein; Stents; Ticlopidine; Tirofiban; Tyrosine	2005
Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Im Journal of the American College of Cardiology, 2008, Mar-25, Volume: 51, Issue:12 Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Diabetes Mellitus; Diabetic Angiopathies; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Hyperplasia; Male; Middle Aged; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome; Tunica Intima	2008
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study. Journal of the American College of Cardiology, 2008, Apr-22, Volume: 51, Issue:16 Topics: Absorbable Implants; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Chromium Alloys; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Risk; Thromboembolism; Ticlopidine; Time Factors	2008

Other Studies

82 other study(ies) available for clopidogrel and Diabetes Mellitus

Article	Year
The comparison between the effects of aspirin and clopidogrel monotherapy on postoperative bleeding in diabetic patients after off-pump coronary artery bypass surgery. Reviews in cardiovascular medicine, 2021, Sep-24, Volume: 22, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Artery Bypass, Off-Pump; Diabetes Mellitus; Humans; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine	2021
The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:19 Topics: Aged; Alleles; Blood Platelets; Clopidogrel; Cross-Sectional Studies; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Resistance; Egypt; Female; Genotype; Humans; Male; Middle Aged; Obesity; Peripheral Vascular Diseases; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide	2021
Application of Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping Score for Efficacy of Clopidogrel: Secondary Analysis of the CHANCE Trial. Stroke, 2022, Volume: 53, Issue:2 Topics: Age Factors; Aged; Aspirin; Body Mass Index; Cerebrovascular Disorders; Clopidogrel; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Therapy, Combination; Female; Genotype; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Renal Insufficiency, Chronic; Stroke; Treatment Outcome	2022
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status. The American journal of cardiology, 2022, 05-15, Volume: 171 Topics: Aspirin; Clopidogrel; Diabetes Mellitus; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies	2022
Cost Utility of Prasugrel in Postangioplasty Diabetic Patients. Value in health regional issues, 2022, Volume: 30 Topics: Clopidogrel; Diabetes Mellitus; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Quality of Life; Ticlopidine	2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES. Journal of the American Heart Association, 2023, 01-03, Volume: 12, Issue:1 Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Humans; Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Treatment Outcome	2023
Clopidogrel Monotherapy After 1-Month DAPT in Diabetic Patients Undergoing PCI: Is Less Always More? JACC. Cardiovascular interventions, 2023, 01-09, Volume: 16, Issue:1 Topics: Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Treatment Outcome	2023
MMW Fortschritte der Medizin, 2023, Volume: 165, Issue:9 Topics: Clopidogrel; Diabetes Mellitus; Humans; Platelet Aggregation Inhibitors	2023
Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel. Journal of atherosclerosis and thrombosis, 2023, Dec-01, Volume: 30, Issue:12 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Diabetes Mellitus; Humans; Ischemia; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Treatment Outcome	2023
Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium. Cardiovascular diabetology, 2023, 09-07, Volume: 22, Issue:1 Topics: Blood Platelets; Clopidogrel; Diabetes Mellitus; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention	2023
Microvesicles from patients with acute coronary syndrome enhance platelet aggregation. Scandinavian journal of clinical and laboratory investigation, 2019, Volume: 79, Issue:7 Topics: Acute Coronary Syndrome; Aged; Cell-Derived Microparticles; Clopidogrel; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors	2019
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention. Journal of cardiovascular translational research, 2020, Volume: 13, Issue:4 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug Resistance; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome	2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score. JACC. Cardiovascular interventions, 2020, 03-09, Volume: 13, Issue:5 Topics: Age Factors; Aged; Body Mass Index; Clinical Decision Rules; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Databases, Factual; Diabetes Mellitus; Drug Resistance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2020
Comparison between ticagrelor versus clopidogrel in long term outcomes of Taiwanese diabetic subjects with acute coronary syndrome undergoing successful revascularization: From TSOC ACS-DM registry. Medicine, 2020, Volume: 99, Issue:19 Topics: Acute Coronary Syndrome; Clopidogrel; Comorbidity; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Mortality; Patient Readmission; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Registries; Secondary Prevention; Taiwan; Ticagrelor; Treatment Outcome	2020
IL-1R (Interleukin-1 Receptor) Signaling and Attenuated Hepatic CYP (Cytochrome P450) 2C Expression: Explanation for Higher Rate of Clopidogrel Resistance in Patients With Diabetes Mellitus? Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:6 Topics: Animals; Clopidogrel; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Diet; Disease Models, Animal; Humans; Mice; Obesity; Receptors, Interleukin-1	2020
Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus. The American journal of cardiology, 2021, 03-01, Volume: 142 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Dual Anti-Platelet Therapy; Duration of Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Care; Proportional Hazards Models; Registries; Risk Assessment; Stroke	2021
Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome. The American journal of cardiology, 2021, 06-01, Volume: 148 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Case-Control Studies; Clopidogrel; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Heart Failure; Hemorrhage; Hospitalization; Humans; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; ST Elevation Myocardial Infarction; Stroke Volume; Ticagrelor; Treatment Outcome	2021
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury. Clinical and experimental nephrology, 2021, Volume: 25, Issue:10 Topics: Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Diabetes Mellitus; Female; Gastroesophageal Reflux; Glomerular Filtration Rate; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Kidney; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Steroids; Time Factors	2021
Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Patients with Coronary Artery Disease Treated with Clopidogrel and Prasugrel. Journal of atherosclerosis and thrombosis, 2022, Jul-01, Volume: 29, Issue:7 Topics: Blood Platelets; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Renal Insufficiency, Chronic; Ticlopidine	2022
Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database. Frontiers in endocrinology, 2021, Volume: 12 Topics: Acute Coronary Syndrome; Angina, Unstable; Aspirin; Beijing; Clopidogrel; Databases, Factual; Diabetes Mellitus; Hospitalization; Humans; Insurance, Health; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Treatment Outcome	2021
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary Intervention. Journal of the American Heart Association, 2017, Mar-29, Volume: 6, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Aged; Blood Platelets; Clopidogrel; Comorbidity; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticagrelor; Ticlopidine; Troponin	2017
Recommendations on the Clinical Use of Compound Danshen Dripping Pills. Chinese medical journal, 2017, Apr-20, Volume: 130, Issue:8 Topics: Angina Pectoris; Aspirin; Camphanes; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Drugs, Chinese Herbal; Humans; Meta-Analysis as Topic; Panax notoginseng; Salvia miltiorrhiza; Ticlopidine	2017
Prevention of Cardiovascular Events in Patients With Diabetes: How Beneficial Is Dual Antiplatelet Therapy? Circulation, 2017, 05-02, Volume: 135, Issue:18 Topics: Aspirin; Belgium; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Stroke; Ticagrelor; Treatment Outcome	2017
Management of diabetic patients hospitalized for acute coronary syndromes: a prospective multicenter registry. Journal of cardiovascular medicine (Hagerstown, Md.), 2017, Volume: 18, Issue:8 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Clopidogrel; Coronary Angiography; Diabetes Mellitus; Disease Management; Female; Hospitalization; Humans; Hyperglycemia; Italy; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Registries; Ticagrelor; Ticlopidine	2017
Evaluation of On-Clopidogrel platelet reactivity overtime, SYNTAX SCORE, genetic polymorphisms and their relationship to one year clinical outcomes in STEMI patients undergoing PCI. Minerva cardioangiologica, 2018, Volume: 66, Issue:1 Topics: Adult; Aged; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymerase Chain Reaction; Polymorphism, Genetic; Prospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Ticlopidine; Time Factors	2018
Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease. Pharmacotherapy, 2017, Volume: 37, Issue:10 Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Cohort Studies; Diabetes Mellitus; Drug Utilization Review; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Renal Insufficiency, Chronic; Ticagrelor; Ticlopidine	2017
Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy. Coronary artery disease, 2018, Volume: 29, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Aged; Case-Control Studies; Clopidogrel; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Greece; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propensity Score; Proportional Hazards Models; Prospective Studies; Stroke; Ticagrelor; Ticlopidine	2018
The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry. Coronary artery disease, 2018, Volume: 29, Issue:4 Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Humans; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Prospective Studies; Registries; Ticagrelor	2018
Clopidogrel utilization in patients with coronary artery disease and diabetes mellitus: should we determine CYP2C192 genotype? European journal of clinical pharmacology, 2018, Volume: 74, Issue:12* Topics: Adult; Aged; Blood Platelets; Clopidogrel; Coronary Artery Disease; Cross-Sectional Studies; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Diabetic Angiopathies; Female; Genotype; Heterozygote; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Young Adult	2018
Comparative effectiveness and safety of antiplatelet drugs in patients with diabetes mellitus and acute coronary syndrome. Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:12 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Cohort Studies; Comorbidity; Comparative Effectiveness Research; Diabetes Mellitus; Female; Hemorrhage; Hospital Mortality; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Stroke; Ticagrelor; Treatment Outcome; United States	2018
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention. International journal of cardiology, 2019, Jan-15, Volume: 275 Topics: Acute Coronary Syndrome; Aged; Cause of Death; Clopidogrel; Comorbidity; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prognosis; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Survival Rate; United States	2019
Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention. Medicine, 2019, Volume: 98, Issue:11 Topics: Aged; Clopidogrel; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Period; Prasugrel Hydrochloride; Republic of Korea; Thromboembolism; Ticagrelor	2019
Predictors of strut coverage of drug eluting stent implantation in diabetic patients- Is only on-clopidogrel platelet reactivity enough? Reply. International journal of cardiology, 2019, 05-15, Volume: 283 Topics: Blood Platelets; Clopidogrel; Diabetes Mellitus; Drug-Eluting Stents; Humans; Ticlopidine	2019
Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy. Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:3 Topics: Acute Coronary Syndrome; Age Factors; Aged; Aged, 80 and over; Aging; Aspirin; Clopidogrel; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor	2019
Predictors of strut coverage of drug eluting stent in diabetic patients - Is only on-clopidogrel platelet reactivity enough? International journal of cardiology, 2019, 08-01, Volume: 288 Topics: Blood Platelets; Clopidogrel; Diabetes Mellitus; Drug-Eluting Stents; Humans; Ticlopidine	2019
Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy. Vascular pharmacology, 2019, Volume: 120 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Biomarkers; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Vitamin D; Vitamin D Deficiency	2019
Therapy with ticagrelor for ST-elevated acute coronary syndrome accompanied by diabetes mellitus. European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:3 Suppl Topics: Acute Coronary Syndrome; Aged; Atrial Function, Left; Clopidogrel; Diabetes Mellitus; Electrocardiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Random Allocation; Ticagrelor; Treatment Outcome	2019
Thiazolidinedione usage is associated with decreased response to clopidogrel in DM patients. International journal of cardiology, 2013, Sep-20, Volume: 168, Issue:1 Topics: Aged; Clopidogrel; Cohort Studies; Diabetes Mellitus; Drug Interactions; Female; Humans; Male; Middle Aged; Prospective Studies; Registries; Thiazolidinediones; Ticlopidine; Treatment Outcome	2013
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thrombosis and haemostasis, 2013, Volume: 110, Issue:1 Topics: Aged; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Female; Humans; Kidney Diseases; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Activation; Platelet Function Tests; Preoperative Care; Prospective Studies; Receptors, Purinergic P2Y12; Risk; Thrombosis; Ticlopidine; Treatment Outcome	2013
Impact of CYP2C19 polymorphism on clinical outcome following coronary stenting is more important in non-diabetic than diabetic patients. Thrombosis research, 2014, Volume: 134, Issue:1 Topics: Aged; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Female; Genotype; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Stents; Ticlopidine	2014
Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World journal of urology, 2015, Volume: 33, Issue:6 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Comorbidity; Coumarins; Diabetes Mellitus; Female; Humans; Hypertension; Kidney Calculi; Male; Middle Aged; Obesity; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Prevalence; Prospective Studies; Risk Factors; Ticlopidine; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urolithiasis; Young Adult	2015
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy. Atherosclerosis, 2015, Volume: 242, Issue:1 Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Drug Synergism; Drug Therapy, Combination; Endothelium, Vascular; Female; Genotype; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Smoking; Stents; Thrombophilia; Ticlopidine; Vasodilation	2015
Prognostic impact of high residual platelet reactivity after chronic total occlusion percutaneous coronary intervention in patients with diabetes mellitus. International journal of cardiology, 2015, Dec-15, Volume: 201 Topics: Aged; Blood Platelets; Chronic Disease; Clopidogrel; Coronary Occlusion; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Incidence; Italy; Male; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prognosis; Retrospective Studies; Survival Rate; Ticlopidine; Time Factors	2015
Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. Journal of the American College of Cardiology, 2015, Sep-08, Volume: 66, Issue:10 Topics: Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Cause of Death; Clopidogrel; Cohort Studies; Coronary Artery Disease; Databases, Factual; Diabetes Mellitus; Drug Administration Schedule; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Insulin; Long-Term Care; Male; Medicare; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Postoperative Care; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome; United States; Veterans Disability Claims	2015
Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2016, Volume: 25, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aspirin; Carotid Stenosis; Cilostazol; Clopidogrel; Diabetes Mellitus; Drug Resistance; Drug Therapy, Combination; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation; Platelet Aggregation Inhibitors; Premedication; Prospective Studies; Purinergic P2Y Receptor Antagonists; Smoking; Stents; Tetrazoles; Ticlopidine	2016
Aspirin in the prevention of cardiovascular events in patients with diabetes. Postgraduate medicine, 2016, Volume: 128, Issue:2 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Drug Administration Schedule; Half-Life; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2016
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy. Journal of thrombosis and thrombolysis, 2016, Volume: 42, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticagrelor; Ticlopidine	2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. Journal of the American College of Cardiology, 2016, May-17, Volume: 67, Issue:19 Topics: Acute Coronary Syndrome; Age Factors; Aged; Anemia; Aspirin; Body Mass Index; Clopidogrel; Cohort Studies; Coronary Thrombosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Medication Adherence; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Renal Insufficiency; Risk Assessment; Smoking; Ticlopidine; United States	2016
Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016, Jun-20, Volume: 12, Issue:3 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2016
Identifying clinically relevant sources of variability: The clopidogrel challenge. Clinical pharmacology and therapeutics, 2017, Volume: 101, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Body Mass Index; Clopidogrel; Computer Simulation; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Interactions; Female; Gastrointestinal Absorption; Half-Life; Humans; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Socioeconomic Factors; Ticlopidine	2017
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System. American heart journal, 2016, Volume: 179 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin	2016
Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome. BMC cardiovascular disorders, 2016, 12-08, Volume: 16, Issue:1 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Diabetes Mellitus; Female; Follow-Up Studies; Graft Occlusion, Vascular; Hemorrhage; Humans; Incidence; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Poland; Prospective Studies; Thrombosis; Ticlopidine	2016
Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. Journal of the American College of Cardiology, 2008, Jun-10, Volume: 51, Issue:23 Topics: Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Survival Analysis; Ticlopidine; Time Factors; Treatment Outcome	2008
The evolution of thienopyridine therapy clopidogrel duration, diabetes, and drug-eluting stents. Journal of the American College of Cardiology, 2008, Jun-10, Volume: 51, Issue:23 Topics: Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Disease Progression; Drug-Eluting Stents; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Ticlopidine; Time Factors; Treatment Outcome	2008
Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thrombosis and haemostasis, 2008, Volume: 100, Issue:1 Topics: Aged; Aspirin; Baltimore; Biomarkers; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Treatment Outcome	2008
Saving lives, money and resources: drug and CABG/PCI use after myocardial infarction in a Swedish record-linkage study. The European journal of health economics : HEPAC : health economics in prevention and care, 2010, Volume: 11, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Atherectomy; Catheter Ablation; Clopidogrel; Coronary Artery Bypass; Diabetes Mellitus; Drug Therapy, Combination; Female; Health Care Costs; Hospital Costs; Humans; Male; Medical Record Linkage; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Proportional Hazards Models; Registries; Risk Factors; Simvastatin; Sweden; Ticlopidine; Treatment Outcome	2010
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. The American journal of cardiology, 2009, Nov-01, Volume: 104, Issue:9 Topics: Acute Coronary Syndrome; Aged; Anemia; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Drug Utilization; Female; Humans; Logistic Models; Male; Middle Aged; Patient Discharge; Platelet Aggregation Inhibitors; Registries; Smoking; Stents; Stroke; Stroke Volume; Ticlopidine; United States; Warfarin	2009
Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication. Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:1 Topics: Acute Coronary Syndrome; Angina Pectoris; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Coronary Artery Disease; Creatine Kinase, MB Form; Diabetes Mellitus; Drug Therapy, Combination; Flow Cytometry; Humans; Myocardium; Necrosis; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors; Treatment Outcome; Troponin I; Up-Regulation	2010
Enhanced post-clopidogrel platelet reactivity in diabetic patients is independently related to plasma fibrinogen level but not to glycemic control. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:11 Topics: Blood Glucose; Clopidogrel; Diabetes Mellitus; Fibrinogen; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine	2009
Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years. Journal of the American College of Cardiology, 2010, Feb-16, Volume: 55, Issue:7 Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Creatinine; Diabetes Mellitus; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Stroke Volume; Ticlopidine	2010
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. Journal of the American College of Cardiology, 2010, Mar-16, Volume: 55, Issue:11 Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Treatment Outcome	2010
Glycemic control and clopidogrel response. American heart journal, 2010, Volume: 159, Issue:6 Topics: Blood Glucose; Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus; Glycated Hemoglobin; Glycemic Index; Humans; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine	2010
Clinical predictors of high posttreatment platelet reactivity to clopidogrel in Koreans. Cardiovascular therapeutics, 2012, Volume: 30, Issue:1 Topics: Age Factors; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Asian People; Biomarkers; Blood Platelets; C-Reactive Protein; Chi-Square Distribution; Chronic Disease; Clopidogrel; Diabetes Mellitus; Female; Humans; Kidney Diseases; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Republic of Korea; Risk Assessment; Risk Factors; Sex Factors; Smoking; Stents; Ticlopidine; Treatment Outcome	2012
[Specificities of diabetes in acute coronary syndromes]. Revue medicale suisse, 2011, Jun-01, Volume: 7, Issue:297 Topics: Acute Coronary Syndrome; Algorithms; Angioplasty; Anti-Inflammatory Agents, Non-Steroidal; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Enoxaparin; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Humans; Hypoglycemic Agents; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Stents; Thiophenes; Ticlopidine; Treatment Outcome	2011
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. The Medical journal of Australia, 2011, Aug-01, Volume: 195, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Australia; Clopidogrel; Comorbidity; Coronary Occlusion; Coronary Restenosis; Coronary Thrombosis; Diabetes Mellitus; Drug Utilization; Drug-Eluting Stents; Emergencies; Female; Hemorrhage; Hospital Mortality; Humans; Logistic Models; Male; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Renal Insufficiency; Shock, Cardiogenic; Ticlopidine	2011
Stent-related cardiac events beyond three years after implantation of the sirolimus-eluting stent (from the EVASTENT Patients). The American journal of cardiology, 2011, Nov-15, Volume: 108, Issue:10 Topics: Clopidogrel; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Matched-Pair Analysis; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Registries; Sirolimus; Ticlopidine	2011
Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. The American journal of cardiology, 2011, Nov-01, Volume: 108, Issue:9 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Aspirin; Cardiac Catheterization; Clopidogrel; Diabetes Mellitus; Female; Fibrinolytic Agents; Heart Failure; Hemorrhage; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Mechanical Thrombolysis; Middle Aged; Middle East; Myocardial Revascularization; Platelet Aggregation Inhibitors; Registries; Sex Distribution; Shock, Cardiogenic; Smoking; Stroke; Ticlopidine	2011
Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin. Platelets, 2013, Volume: 24, Issue:2 Topics: Adenosine Diphosphate; Aged; Alprostadil; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; Diabetes Mellitus; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Ticlopidine	2013
The extent of P2Y12 inhibition by clopidogrel in diabetes mellitus patients with acute coronary syndrome is not related to glycaemic control: roles of white blood cell count and body weight. Thrombosis and haemostasis, 2012, Volume: 108, Issue:2 Topics: Acute Coronary Syndrome; Aged; Body Weight; Clopidogrel; Diabetes Complications; Diabetes Mellitus; Female; Flow Cytometry; Glycated Hemoglobin; Humans; Inflammation; Leukocyte Count; Leukocytes; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Phosphorylation; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine	2012
Clinical efficacy and safety of biodegradable polymer-based sirolimus-eluting stents in patients with diabetes mellitus insight from the 4-year results of the create study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Jun-01, Volume: 81, Issue:7 Topics: Absorbable Implants; Aged; Aspirin; Cardiovascular Agents; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2013
Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. JAMA, 2012, Sep-05, Volume: 308, Issue:9 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Data Collection; Denmark; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Registries; Risk; Ticlopidine	2012
Antiplatelet therapy following myocardial infarction in patients with diabetes. JAMA, 2012, Sep-05, Volume: 308, Issue:9 Topics: Cardiovascular Diseases; Clopidogrel; Diabetes Mellitus; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	2012
Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy. International journal of cardiology, 2013, Sep-20, Volume: 168, Issue:1 Topics: Acute Coronary Syndrome; Aged; Blood Platelets; Clopidogrel; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine; Treatment Outcome	2013
Pharmaceutical care for patients with acute myocardial infarction in Hungary. International journal of clinical pharmacology and therapeutics, 2013, Volume: 51, Issue:2 Topics: Acute Disease; Adult; Aged; Aspirin; Clopidogrel; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Hungary; Incidence; Male; Middle Aged; Muscle Hypotonia; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk; Secondary Prevention; Ticlopidine; Treatment Outcome; Young Adult	2013
Clopidogrel and percutaneous coronary interventions. JAMA, 2003, Apr-16, Volume: 289, Issue:15 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Diabetes Mellitus; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Risk; Ticlopidine	2003
[Prophylaxis of stroke]. Praxis, 2005, Jul-27, Volume: 94, Issue:30-31 Topics: Age Factors; Aged; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Brain Ischemia; Carotid Stenosis; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diet; Drug Therapy, Combination; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Life Style; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Smoking Cessation; Stents; Stroke; Ticlopidine; Time Factors	2005
Influence of aspirin resistance on platelet function profiles in patients on long-term aspirin and clopidogrel after percutaneous coronary intervention. The American journal of cardiology, 2006, Jan-01, Volume: 97, Issue:1 Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Collagen Type I; Diabetes Mellitus; Drug Resistance; Drug Therapy, Combination; Epinephrine; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Vasoconstrictor Agents	2006
Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes, 2006, Volume: 55, Issue:3 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Substance Withdrawal Syndrome; Thrombosis; Ticlopidine	2006
[Postoperative antithrombotic treatment in diabetic patients]. Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95 Suppl 1 Topics: Anticoagulants; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Diabetes Mellitus; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Thrombosis; Ticlopidine; Warfarin	2006
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation, 2007, Jun-26, Volume: 115, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2007
[Antiplatelet treatment after acute and chronic ischemic heart and brain events is insufficient according to recommendations]. Ugeskrift for laeger, 2008, Mar-31, Volume: 170, Issue:14 Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Aspirin; Brain Infarction; Brain Ischemia; Clopidogrel; Diabetes Mellitus; Dipyridamole; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	2008
Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:3 Topics: Abciximab; Adult; Antibodies, Monoclonal; Blood Platelets; Clopidogrel; Cytoplasmic Granules; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; In Vitro Techniques; Male; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet-Derived Growth Factor; Ticlopidine	2002